image credit: Unsplash

FDA seeks more time to review Moderna’s coronavirus vaccine for adolescents

November 1, 2021


Moderna’s and Pfizer’s vaccines are based on the same messenger RNA technology and had near-identical results in clinical testing, strong findings that set up initial U.S. authorizations within weeks of one another. Both have since become the most widely used shots in the country, accounting for more than 95% of the doses administered in the U.S. since distribution began late last year.

While there are many similarities between the two shots, some differences have emerged, too.

Read More on Biopharma Dive